10-116089793-C-G
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_005264.8(GFRA1):c.1145G>C(p.Gly382Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000421 in 1,614,074 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005264.8 missense
Scores
Clinical Significance
Conservation
Publications
- renal hypodysplasia/aplasia 4Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152090Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000756 AC: 19AN: 251416 AF XY: 0.0000736 show subpopulations
GnomAD4 exome AF: 0.0000424 AC: 62AN: 1461866Hom.: 0 Cov.: 32 AF XY: 0.0000385 AC XY: 28AN XY: 727234 show subpopulations
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74414 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1145G>C (p.G382A) alteration is located in exon 9 (coding exon 8) of the GFRA1 gene. This alteration results from a G to C substitution at nucleotide position 1145, causing the glycine (G) at amino acid position 382 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at